Cargando…

Could treatment with botulinum toxin protect against subsequent infection with COVID-19?

We report comparative results, over three months, of the impact of SARS-CoV2 in our patients injected with botulinum toxin for functional purposes, compared to the general population. Botulinum neurotoxin type A (BoNT/A) is known to block acetylcholine (ACh) as well as many other neuroreceptors and...

Descripción completa

Detalles Bibliográficos
Autores principales: Batifol, D., Finiels, P.J., Galmiche, S., Jammet, P., de Boutray, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205559/
https://www.ncbi.nlm.nih.gov/pubmed/34144245
http://dx.doi.org/10.1016/j.jormas.2021.06.003
_version_ 1783708527281307648
author Batifol, D.
Finiels, P.J.
Galmiche, S.
Jammet, P.
de Boutray, M.
author_facet Batifol, D.
Finiels, P.J.
Galmiche, S.
Jammet, P.
de Boutray, M.
author_sort Batifol, D.
collection PubMed
description We report comparative results, over three months, of the impact of SARS-CoV2 in our patients injected with botulinum toxin for functional purposes, compared to the general population. Botulinum neurotoxin type A (BoNT/A) is known to block acetylcholine (ACh) as well as many other neuroreceptors and neuromodulators. The recent mention of a potential protective effect of nicotine in COVID 19, by blocking ACh, attracted our attention and guided the present study. Our results show a significant difference between the number of infected individuals in the general population and the number of patients injected with BoNT/A who showed signs of COVID 19.
format Online
Article
Text
id pubmed-8205559
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-82055592021-06-16 Could treatment with botulinum toxin protect against subsequent infection with COVID-19? Batifol, D. Finiels, P.J. Galmiche, S. Jammet, P. de Boutray, M. J Stomatol Oral Maxillofac Surg Short Communication We report comparative results, over three months, of the impact of SARS-CoV2 in our patients injected with botulinum toxin for functional purposes, compared to the general population. Botulinum neurotoxin type A (BoNT/A) is known to block acetylcholine (ACh) as well as many other neuroreceptors and neuromodulators. The recent mention of a potential protective effect of nicotine in COVID 19, by blocking ACh, attracted our attention and guided the present study. Our results show a significant difference between the number of infected individuals in the general population and the number of patients injected with BoNT/A who showed signs of COVID 19. Elsevier Masson SAS. 2022-04 2021-06-16 /pmc/articles/PMC8205559/ /pubmed/34144245 http://dx.doi.org/10.1016/j.jormas.2021.06.003 Text en © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Batifol, D.
Finiels, P.J.
Galmiche, S.
Jammet, P.
de Boutray, M.
Could treatment with botulinum toxin protect against subsequent infection with COVID-19?
title Could treatment with botulinum toxin protect against subsequent infection with COVID-19?
title_full Could treatment with botulinum toxin protect against subsequent infection with COVID-19?
title_fullStr Could treatment with botulinum toxin protect against subsequent infection with COVID-19?
title_full_unstemmed Could treatment with botulinum toxin protect against subsequent infection with COVID-19?
title_short Could treatment with botulinum toxin protect against subsequent infection with COVID-19?
title_sort could treatment with botulinum toxin protect against subsequent infection with covid-19?
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205559/
https://www.ncbi.nlm.nih.gov/pubmed/34144245
http://dx.doi.org/10.1016/j.jormas.2021.06.003
work_keys_str_mv AT batifold couldtreatmentwithbotulinumtoxinprotectagainstsubsequentinfectionwithcovid19
AT finielspj couldtreatmentwithbotulinumtoxinprotectagainstsubsequentinfectionwithcovid19
AT galmiches couldtreatmentwithbotulinumtoxinprotectagainstsubsequentinfectionwithcovid19
AT jammetp couldtreatmentwithbotulinumtoxinprotectagainstsubsequentinfectionwithcovid19
AT deboutraym couldtreatmentwithbotulinumtoxinprotectagainstsubsequentinfectionwithcovid19